---
title: "Electra Therapeutics adopts amended, restated bylaws effective at IPO close"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299678681.md"
description: "Electra Therapeutics adopted amended and restated bylaws effective September 21, 2026, coinciding with its Initial Public Offering (IPO) closing. The IPO involved the sale of 23,333,334 common shares at $15 per share, raising approximately $350 million in gross proceeds. These governance changes were filed alongside an amended certificate of incorporation in Delaware on the same date."
datetime: "2026-09-21T20:01:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299678681.md)
  - [en](https://longbridge.com/en/news/299678681.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299678681.md)
generator: "portal-rs"
---

# Electra Therapeutics adopts amended, restated bylaws effective at IPO close

-   Electra Therapeutics adopted amended and restated bylaws effective Sept. 21, 2026 in connection with its IPO closing. \* Changes took effect alongside an amended and restated certificate of incorporation filed in Delaware on the same date. \* IPO closed Sept. 21, 2026 with 23,333,334 common shares sold at USD 15 per share, raising about USD 350 million gross. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Electra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-396646), on September 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ETRA.US](https://longbridge.com/en/quote/ETRA.US.md)

## Related News & Research

- [OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake](https://longbridge.com/en/news/300167793.md)
- [OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million](https://longbridge.com/en/news/299946121.md)
- [EXL President Vikas Bhalla disposes of $389,180 of common shares](https://longbridge.com/en/news/300823152.md)
- [ON Semiconductor Group President Sudhir Gopalswamy disposes of 15,578 common shares for $1,246,240](https://longbridge.com/en/news/300826639.md)
- [Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership](https://longbridge.com/en/news/299696744.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**